Upstate’s Bone Marrow Transplant Program is awarded re-accreditation
The Upstate Cancer Center Bone Marrow Transplant Program received re-accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT). FACT is an internationally recognized accrediting body for hospitals and medical institutions offering stem cell transplant, and indicates the accredited institution has met the most rigorous standards in every aspect of stem cell therapy. This covers the entire spectrum of stem cell therapy, from clinical care to donor management, cell collection, processing, storage, transportation, administration, and cell release.
Upstate’s Bone Marrow Transplant Program saw an increase in transplants in the past year, while also implementing new processes and staffing that ensure seamless, exemplary patient care through all phases of transplant. “The FACT re-accreditation is an affirmation that the changes our program has implemented are working to provide care that is up to the highest standard,” said Thomas Coyle, MD, director of the Bone Marrow Transplant Program. “The stringent criteria required for this accreditation make it an honor for us, but also an added assurance for our patients and their loved ones that the care we provide is excellent, from preadmission through follow up.”
Since 1992, more than 800 bone marrow transplants have been performed at Upstate. Patients receive transplants for non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, multiple myeloma, leukemia and selected solid tumors. The Upstate Bone Marrow Transplant program performs both autologous and match-related allogenic transplants.
FACT-JACIE standards are defined by leading experts based on the latest knowledge of the field of cellular therapy transplantation. Upstate has been found to be in compliance with these rigorous standards as well as governmental regulations. “We are pleased that the Upstate Bone Marrow Transplant Program has met the requirements of the Foundation and has been granted re-accreditation,” said Phyllis Warkentin, MD, FACT’s chief medical officer.
FACT accreditation is attained through evaluation of submitted documentation and on-site inspection to determine if an organization is in compliance with current FACT standards and the FDA’s current rules for Good Tissue Practice. FACT standards are defined by leading experts based on the latest knowledge of the field of cellular therapy. The Bone Marrow Transplant Program’s clinical, peripheral blood collection and processing facilities were included in the accreditation inspection.
Caption: Thomas Coyle, MD, is director of the Bone Marrow Transplant Program.